Macrofilaricidal Efficacy of Repeated Doses of Ivermectin for the Treatment of River Blindness

We use a mathematical model fit to clinical trial data to estimate the efficacy of multiple-dose ivermectin regimens against onchocerciasis. We found marked macrofilaricidal activity of regimens used in routine mass drug administration, calling for revised projections on elimination timeframes.

[1]  S. D. de Vlas,et al.  Modelling the elimination of river blindness using long-term epidemiological and programmatic data from Mali and Senegal , 2017, Epidemics.

[2]  L. Coffeng,et al.  Progress towards onchocerciasis elimination in the participating countries of the African Programme for Onchocerciasis Control: epidemiological evaluation results , 2016, Infectious Diseases of Poverty.

[3]  A. Kuesel.  Research for new drugs for elimination of onchocerciasis in Africa , 2016, International journal for parasitology. Drugs and drug resistance.

[4]  D. Boakye,et al.  Does Increasing Treatment Frequency Address Suboptimal Responses to Ivermectin for the Control and Elimination of River Blindness? , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  A. Eisenbarth,et al.  Ongoing Transmission of Onchocerca volvulus after 25 Years of Annual Ivermectin Mass Treatments in the Vina du Nord River Valley, in North Cameroon , 2016, PLoS neglected tropical diseases.

[6]  M. Grillet,et al.  Evidence of suppression of onchocerciasis transmission in the Venezuelan Amazonian focus , 2016, Parasites & Vectors.

[7]  L. Coffeng,et al.  River Blindness: Mathematical Models for Control and Elimination. , 2016, Advances in parasitology.

[8]  L. Coffeng,et al.  Required duration of mass ivermectin treatment for onchocerciasis elimination in Africa: a comparative modelling analysis , 2015, Parasites & Vectors.

[9]  P. Enyong,et al.  Situation analysis of parasitological and entomological indices of onchocerciasis transmission in three drainage basins of the rain forest of South West Cameroon after a decade of ivermectin treatment , 2015, Parasites & Vectors.

[10]  M. Basáñez,et al.  The potential impact of moxidectin on onchocerciasis elimination in Africa: an economic evaluation based on the Phase II clinical trial data , 2015, Parasites & Vectors.

[11]  A. Hoerauf,et al.  Therapeutic Efficacy and Macrofilaricidal Activity of Doxycycline for the Treatment of River Blindness , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  Progress toward eliminating onchocerciasis in the WHO Region of the Americas: verification of elimination of transmission in Mexico. , 2015, Releve epidemiologique hebdomadaire.

[13]  L. Coffeng,et al.  Elimination of African Onchocerciasis: Modeling the Impact of Increasing the Frequency of Ivermectin Mass Treatment , 2014, PloS one.

[14]  M. Basáñez,et al.  Reaching the London Declaration on Neglected Tropical Diseases Goals for Onchocerciasis: An Economic Evaluation of Increasing the Frequency of Ivermectin Treatment in Africa , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  A. Onapa,et al.  Transmission of Onchocerca volvulus continues in Nyagak-Bondo focus of northwestern Uganda after 18 years of a single dose of annual treatment with ivermectin. , 2013, The American journal of tropical medicine and hygiene.

[16]  M. Basáñez,et al.  Uncertainty Surrounding Projections of the Long-Term Impact of Ivermectin Treatment on Human Onchocerciasis , 2013, PLoS neglected tropical diseases.

[17]  L. Konaté,et al.  Proof-of-Principle of Onchocerciasis Elimination with Ivermectin Treatment in Endemic Foci in Africa: Final Results of a Study in Mali and Senegal , 2012, PLoS neglected tropical diseases.

[18]  S. Cousens,et al.  Impact of long-term treatment of onchocerciasis with ivermectin in Kaduna State, Nigeria: first evidence of the potential for elimination in the operational area of the African Programme for Onchocerciasis Control , 2012, Parasites & Vectors.

[19]  A. Hoerauf,et al.  Retarded Onchocerca volvulus L1 to L3 larval development in the Simulium damnosum vector after anti-wolbachial treatment of the human host , 2012, Parasites & Vectors.

[20]  P. Enyong,et al.  Seventeen years of annual distribution of ivermectin has not interrupted onchocerciasis transmission in North Region, Cameroon. , 2011, The American journal of tropical medicine and hygiene.

[21]  P. Diggle,et al.  The Geographic Distribution of Loa loa in Africa: Results of Large-Scale Implementation of the Rapid Assessment Procedure for Loiasis (RAPLOA) , 2011, PLoS neglected tropical diseases.

[22]  T. Geary,et al.  Flubendazole: a candidate macrofilaricide for lymphatic filariasis and onchocerciasis field programs , 2011, Expert review of anti-infective therapy.

[23]  V. Isham,et al.  Rates of microfilarial production by Onchocerca volvulus are not cumulatively reduced by multiple ivermectin treatments , 2008, Parasitology.

[24]  M. Boussinesq,et al.  Effect of single-dose ivermectin on Onchocerca volvulus: a systematic review and meta-analysis. , 2008, The Lancet. Infectious diseases.

[25]  E. Cupp,et al.  Short report: impact of ivermectin community-level treatments on elimination of adult Onchocerca volvulus when individuals receive multiple treatments per year. , 2005, The American journal of tropical medicine and hygiene.

[26]  Bradley P. Carlin,et al.  Bayesian measures of model complexity and fit , 2002 .

[27]  M. Boussinesq,et al.  Effects of standard and high doses of ivermectin on adult worms of Onchocerca volvulus: a randomised controlled trial , 2002, The Lancet.

[28]  M. Iorio.  Discussion to the paper by Spiegelhalter et al., “Bayesian measures of complexity and fit” , 2002 .

[29]  M. Boussinesq,et al.  Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection , 1997, The Lancet.

[30]  S. Kläger,et al.  Viability and fertility of adult Onchocerca volvulus after 6 years of treatment with ivermectin , 1996, Tropical medicine & international health : TM & IH.

[31]  J. Habbema,et al.  Irreversible effects of ivermectin on adult parasites in onchocerciasis patients in the Onchocerciasis Control Programme in West Africa. , 1995, The Journal of infectious diseases.

[32]  E. Cupp,et al.  Effects of three-month doses of ivermectin on adult Onchocerca volvulus. , 1992, The American journal of tropical medicine and hygiene.

[33]  E. Cupp,et al.  Comparison of the effects of a single dose and of four six-monthly doses of ivermectin on adult Onchocerca volvulus. , 1991, The American journal of tropical medicine and hygiene.

[34]  J. Habbema,et al.  The reproductive lifespan of Onchocerca volvulus in West African savanna. , 1991, Acta tropica.

[35]  Burkina Faso,et al.  Population dynamics of Onchocerca volvulus after 7 to 8 years of vector control in West Africa. , 1987, Acta tropica.

[36]  B. Jean,et al.  Investigations on female Onchocerca volvulus for the evaluation of drug trials. , 1980, Tropenmedizin und Parasitologie.